Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kestra Medical Technologies (KMTS) Net Margin (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Net Margin for 2 consecutive years, with 145.29% as the latest value for Q4 2025.

  • On a quarterly basis, Net Margin rose 1576.0% to 145.29% in Q4 2025 year-over-year; TTM through Oct 2025 was 186.9%, a 1713.0% increase, with the full-year FY2025 number at 210.88%, up 8428.0% from a year prior.
  • Net Margin was 145.29% for Q4 2025 at Kestra Medical Technologies, down from 133.32% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 133.32% in Q3 2025 to a low of 321.15% in Q2 2025.